We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mgc Pharmaceuticals Limited | LSE:MXC | London | Ordinary Share | AU000000MXC6 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 22.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Drug & Proprietary Stores | 3.02M | -17.53M | -0.3998 | -0.50 | 9.65M |
From Jan 2023 to Jan 2025
TIDMMXC
RNS Number : 3970Z
MGC Pharmaceuticals Limited
11 January 2024
MGC Pharmaceuticals Ltd.
PDMR Notification
11 January 2024
ASX, LSE: MXC
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes to advise that the following Persons Discharging Managerial Responsibilities (PDMR) have dealt with shares in MGC Pharma, and this notification is made in accordance the UK Market Abuse Regulations.
The shares subject of this notice were issued to the PDMR's as part of their working contracts and as consideration for services rendered in lieu of cash payments
Hot Features
Premium
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Amir Polak
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Chief Pharmaceutical Development
Officer
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- ---------------- ------------------------
AUD A$0.55 600,000 A$330,000
----------------- --------------------- ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 600,000 A$330,000
----------------- --------------------- ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Sabina Suljakovic
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Vice President of Global Quality
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- ---------------- ------------------------
AUD A$0.55 17,000 A$9,350
----------------- --------------------- ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 17,000 A$9,350
----------------- --------------------- ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yair Tal
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Chief Information Security Officer
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- ---------------- ------------------------
AUD A$0.55 300,000 A$165,000
----------------- --------------------- ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 300,000 A$165,000
----------------- --------------------- ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yifat Steuer
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Chief Operating Officer and Deputy
CEO
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
-------------------- ------------------ ---------------- ------------------------
AUD A$0.55 1,100,000 A$605,000
-------------------- ------------------ ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 1,100,000 A$605,000
-------------------- ------------------ ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Rowan Harland
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Company Secretary
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
-------------------- ------------------ ---------------- ------------------------
AUD A$0.55 7,000 A$3,850
-------------------- ------------------ ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 7,000 A$3,850
-------------------- ------------------ ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Ana Arhar Oblak
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Group Financial Controller
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
-------------------- ------------------ ---------------- ------------------------
AUD A$0.55 10,000 A$5,500
-------------------- ------------------ ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 10,000 A$5,500
-------------------- ------------------ ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
-Ends-
Authorised for release by the Managing Director, for further information please contact:
MGC Pharmaceuticals Ltd MGC Pharmaceuticals Ltd Roby Zomer Rowan Harland CEO & Managing Director Company Secretary +61 8 6555 2950 +61 8 6555 2950 info@mgcpharma.co.uk info@mgcpharma.co.uk UK IR/PR Advisers UK Brokers IFC Advisory Oberon Capital Graham Herring / Tim Metcalfe / Aimee McCusker / Adam Pollock Zach Cohen +44 203 179 5300 +44 203 934 6630 aimeemccusker@oberoninvestments.com mgcpharma@investor-focus.co.uk adampollock@oberoninvestments.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHKFLBFZFLEBBL
(END) Dow Jones Newswires
January 11, 2024 04:54 ET (09:54 GMT)
1 Year Mgc Pharmaceuticals Chart |
1 Month Mgc Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
